Latest Biotechnology News

Newport Beach, California--(Newsfile Corp. - August 14, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to announce that its Chief Medical Officer, Dr. McColgan, has been appointed as Clinical Instructor at the University of California, Riverside (UCR), School of Medicine. The UCR School ...
Biotechnology, Health Care/Hospitals
2019-08-14 9:06 AM ET | Vivera Pharmaceuticals, Inc.

Toronto, Ontario--(Newsfile Corp. - August 13, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that on Friday, August 9, 2019, the Company's wholly-owned subsidiary Beleave Kannabis Corp was issued a Research License ("License") under the Cannabis Act and Cannabis Regulations of Canada. ...
Biotechnology, Cannabis
2019-08-13 7:30 AM ET | Beleave Inc.

Toronto, Ontario--(Newsfile Corp. - August 9, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that on July 31, 2019 the company commenced the sale of its Blue Dream strain to medical patients under the Beleave Kannabis Corp. medicinal brand. "Beleave is ...
Biotechnology, Cannabis
2019-08-09 7:35 AM ET | Beleave Inc.

Toronto, Ontario--(Newsfile Corp. - August 8, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announces that its principal regulator, the Ontario Securities Commission, has accepted the Company's application for, and has granted, a management cease trade order ("MCTO"). As previously announced on July 30, 2019, the ...
Biotechnology, Cannabis
2019-08-08 5:00 PM ET | Beleave Inc.

Newport Beach, California--(Newsfile Corp. - August 8, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to welcome Mr. Daniel Baldwin to the Company's Ambassador Board. A long-time advocate for addiction recovery, Mr. Baldwin is helping to promote Vivera's mission of developing non-addictive pain ...
Biotechnology, Health Care/Hospitals
2019-08-08 9:07 AM ET | Vivera Pharmaceuticals, Inc.

Toronto, Ontario--(Newsfile Corp. - August 7, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that the Company has entered into a non-binding letter of intent (the "LOI") that contemplates a business combination with TerraFarma Inc. ("TerraFarma").The precise structure of the transaction, including ...
Biotechnology, Cannabis
2019-08-07 3:47 PM ET | Beleave Inc.

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical") and Asterion Cannabis Inc. ("Asterion") announce that they have entered into an option to purchase agreement (the "Option Agreement"), whereby PreveCeutical has granted to Asterion the right and option (the "Option") ...
Biotechnology, Medical/Pharmaceuticals
2019-08-06 1:59 PM ET | PreveCeutical Medical Inc.

Halifax, Nova Scotia--(Newsfile Corp. - August 6, 2019) - Sona Nanotech Inc. (CSE: SONA) and Expedeon AG (FSE: EXN) (ISIN: DE000A1RFM03), today announced they have entered into a commercial agreement to address limitations in development of complex, multiplex point-of-care (POC) lateral flow assay (LFA) diagnostic tests.Under the terms of the ...
Biotechnology, Medical/Pharmaceuticals
2019-08-06 8:30 AM ET | Sona Nanotech Inc.

Newport Beach, California--(Newsfile Corp. - July 29, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to announce the appointment of Sally Pera to the Company's Advisory Board. A thought leader and corporate strategy expert, Ms. Pera will be instrumental in building integral ...
Biotechnology, Health Care/Hospitals
2019-07-29 8:52 AM ET | Vivera Pharmaceuticals, Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 29, 2019) - NATURALLY SPLENDID ENTERPRISES LTD.
Biotechnology, Health Care/Hospitals
2019-07-29 8:00 AM ET | Naturally Splendid Enterprises Ltd.

Newport Beach, California--(Newsfile Corp. - July 25, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appointment of Brad Townend to Executive Creative Director. In this role, Mr. Townend will be responsible for creating and overseeing the Vivera brand in every aspect ...
Biotechnology, Health Care/Hospitals
2019-07-25 9:03 AM ET | Vivera Pharmaceuticals, Inc.

Newport Beach, California--(Newsfile Corp. - July 22, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appointment of Mr. Greg Cervantes to Director of Government Affairs. Mr. Cervantes specializes in government relations and public policy in many arenas including federal, state, tribal and ...
Biotechnology, Health Care/Hospitals
2019-07-22 9:35 AM ET | Vivera Pharmaceuticals, Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 19, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has been named as a defendant in a lawsuit commenced in the Supreme Court of British Columbia (the "Claim") on July 11, 2019 (Tietz and ...
Biotechnology, Medical/Pharmaceuticals
2019-07-19 7:45 PM ET | PreveCeutical Medical Inc.

Newport Beach, California--(Newsfile Corp. - July 18, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces its continued commitment to the advancement of research and development of cannabidiol (CBD)-based therapies as effective alternatives to opioids in response to newly released federal data regarding t
Biotechnology, Health Care/Hospitals
2019-07-18 8:54 AM ET | Vivera Pharmaceuticals, Inc.

Halifax, Nova Scotia--(Newsfile Corp. - July 16, 2019) - Sona Nanotech Inc. (CSE: SONA) ("Sona" or the "Company") has arranged a debt settlement of $797,953 in amounts owed to certain non-arm's length creditors and included in accounts payable to related parties in the financial statements of Sona (the "Debts"). ...
Biotechnology, Medical/Pharmaceuticals
2019-07-16 8:00 AM ET | Sona Nanotech Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2019) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") is pleased to announce that it has closed its non-brokered private placement through its Korean Subsidiary BiocurePharm, ...
Biotechnology, Medical/Pharmaceuticals
2019-07-11 6:14 PM ET | Biocure Technology Inc.

Newport Beach, California--(Newsfile Corp. - July 11, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appointment of Mehdi Hatamian, Ph.D., as the Company's Senior Scientific Advisor. A key aspect of his role is to assist with advancing the research and development of ...
Biotechnology, Health Care/Hospitals
2019-07-11 8:46 AM ET | Vivera Pharmaceuticals, Inc.

New York, New York--(Newsfile Corp. - July 11, 2019) - Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is pleased to announce the latest updates on its non-opioid therapy for the debilitating pain associated with metastatic skeletal cancer.We have been working hard to commercialize both our Strontium-89 products. ...
Biotechnology
2019-07-11 8:30 AM ET | Q BioMed Inc.

Toronto, Ontario--(Newsfile Corp. - July 11, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") today announced that it has commenced sales of the Company's cannabis oils for the Canadian adult use market, with product expected to hit store shelves early next week."Adding oils to our ...
Biotechnology, Cannabis
2019-07-11 8:24 AM ET | Beleave Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FS
Biotechnology, Medical/Pharmaceuticals
2019-07-09 8:00 AM ET | PreveCeutical Medical Inc.

Toronto, Ontario--(Newsfile Corp. - June 28, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces today the release of its restated Condensed Interim Consolidated Financial Statements for three and nine months ended December 31, 2018, together with its Management, Discussion and Analysis ("MD&A").In October 2018, the ...
Biotechnology, Cannabis
2019-06-28 4:30 PM ET | Beleave Inc.

Sacramento California--(Newsfile Corp. - June 28, 2019) - Conception, a leading cannabis micropropagation company, is pleased to announce the hire of strong industry leader Tad Henderson as Chief Operating Officer (COO). Henderson brings to the Conception team 20-plus years of leadership and operational excellence in highly-regulated environments. As COO, ...
Biotechnology, Cannabis
2019-06-28 10:05 AM ET | Conception

Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA)New York, New York--(Newsfile Corp. - June 28, 2019) - Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has filed an application ...
Biotechnology
2019-06-28 8:30 AM ET | Q BioMed Inc.

Newport Beach, California--(Newsfile Corp. - June 27, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, is pleased to announce the launch of Vivera Cares, a non-profit initiative to help vulnerable community members including those struggling to access non-addictive therapies and medications."Putting patients first is a ...
Biotechnology, Health Care/Hospitals
2019-06-27 8:48 AM ET | Vivera Pharmaceuticals, Inc.

Toronto, Ontario--(Newsfile Corp. - June 27, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has shipped its first order of recreational cannabis products for retail sale in the province of Saskatchewan.Beleave currently distributes recreational cannabis in three other Canadian provinces; ...
Biotechnology, Cannabis
2019-06-27 8:18 AM ET | Beleave Inc.